Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Thoracic Surgery

  Free Subscription


Articles published in Lancet

Retrieve available abstracts of 68 articles:
HTML format



Single Articles


    June 2021
  1. DESHPANDE AA, Sharma V, Bansal R, Jagia P, et al
    Tension pericardial abscess in a patient with tuberculosis: a rare cause of cardiac tamponade.
    Lancet. 2021;397:e15.
    PubMed    


    May 2021
  2. KOO BK, Kang J, Park KW, Rhee TM, et al
    Aspirin versus clopidogrel for chronic maintenance monotherapy after percutaneous coronary intervention (HOST-EXAM): an investigator-initiated, prospective, randomised, open-label, multicentre trial.
    Lancet. 2021 May 14. pii: S0140-6736(21)01063.
    PubMed     Abstract available


    April 2021
  3. SIBBING D, Kastrati A
    Guided P2Y12 inhibitor therapy after percutaneous coronary intervention.
    Lancet. 2021;397:1423-1425.
    PubMed    


  4. GALLI M, Benenati S, Capodanno D, Franchi F, et al
    Guided versus standard antiplatelet therapy in patients undergoing percutaneous coronary intervention: a systematic review and meta-analysis.
    Lancet. 2021;397:1470-1483.
    PubMed     Abstract available


    December 2020
  5. MUNOZ M, Gomez-Ramirez S, Rondinelli MB, Weltert L, et al
    Preoperative intravenous iron for cardiac surgery.
    Lancet. 2020;396:1884.
    PubMed    


  6. MYLES PS, Richards T, Klein A
    Preoperative intravenous iron for cardiac surgery.
    Lancet. 2020;396:1883-1884.
    PubMed    


    November 2020
  7. SILVAIN J, Lattuca B, Beygui F, Range G, et al
    Ticagrelor versus clopidogrel in elective percutaneous coronary intervention (ALPHEUS): a randomised, open-label, phase 3b trial.
    Lancet. 2020 Nov 12. pii: S0140-6736(20)32236.
    PubMed     Abstract available


    October 2020
  8. JEGER RV, Farah A, Ohlow MA, Mangner N, et al
    Long-term efficacy and safety of drug-coated balloons versus drug-eluting stents for small coronary artery disease (BASKET-SMALL 2): 3-year follow-up of a randomised, non-inferiority trial.
    Lancet. 2020 Oct 19. pii: S0140-6736(20)32173.
    PubMed     Abstract available


  9. TAKAHASHI K, Serruys PW, Fuster V, Farkouh ME, et al
    Redevelopment and validation of the SYNTAX score II to individualise decision making between percutaneous and surgical revascularisation in patients with complex coronary artery disease: secondary analysis of the multicentre randomised controlled SYNT
    Lancet. 2020 Oct 8. pii: S0140-6736(20)32114.
    PubMed     Abstract available


    September 2020
  10. MAKKAR RR, Cheng W, Waksman R, Satler LF, et al
    Self-expanding intra-annular versus commercially available transcatheter heart valves in high and extreme risk patients with severe aortic stenosis (PORTICO IDE): a randomised, controlled, non-inferiority trial.
    Lancet. 2020;396:669-683.
    PubMed     Abstract available


    August 2020
  11. LIANG F, Wang X, Wang Q, Yan P, et al
    Predilatation and paravalvular leakage risk in TAVR.
    Lancet. 2020;396:600.
    PubMed    


  12. LANZ J, Kunzi A, Windecker S, Pilgrim T, et al
    Predilatation and paravalvular leakage risk in TAVR - Authors' reply.
    Lancet. 2020;396:600-601.
    PubMed    


  13. FERRARI R, Ford I, Fox K, Challeton JP, et al
    Efficacy and safety of trimetazidine after percutaneous coronary intervention (ATPCI): a randomised, double-blind, placebo-controlled trial.
    Lancet. 2020 Aug 28. pii: S0140-6736(20)31790.
    PubMed     Abstract available


  14. KIM HS, Kang J, Hwang D, Han JK, et al
    Prasugrel-based de-escalation of dual antiplatelet therapy after percutaneous coronary intervention in patients with acute coronary syndrome (HOST-REDUCE-POLYTECH-ACS): an open-label, multicentre, non-inferiority randomised trial.
    Lancet. 2020 Aug 28. pii: S0140-6736(20)31791.
    PubMed     Abstract available


    July 2020
  15. TURAN A, Duncan A, Leung S, Karimi N, et al
    Dexmedetomidine for reduction of atrial fibrillation and delirium after cardiac surgery (DECADE): a randomised placebo-controlled trial.
    Lancet. 2020;396:177-185.
    PubMed     Abstract available


  16. BILOTTA F, Pugliese F
    The evolving clinical use of dexmedetomidine.
    Lancet. 2020;396:145-147.
    PubMed    


  17. MAFHAM MM, Spata E, Goldacre R, Gair D, et al
    COVID-19 pandemic and admission rates for and management of acute coronary syndromes in England.
    Lancet. 2020 Jul 14. pii: S0140-6736(20)31356.
    PubMed     Abstract available


  18. LAM RPK, Wong KW, Wan CK
    Allergic contact dermatitis and tracheobronchitis associated with repeated exposure to tear gas.
    Lancet. 2020 Jul 13. pii: S0140-6736(20)31560.
    PubMed    


    May 2020
  19. HARRIS DA, Willis J, Tomann M
    A new era of coal workers' pneumoconiosis: decades in mines may not be required.
    Lancet. 2020;395:e82.
    PubMed    


    January 2020
  20. MORICE MC
    Patients with left main coronary artery disease: stent or surgery?
    Lancet. 2020;395:167-168.
    PubMed    


    December 2019
  21. HOLM NR, Makikallio T, Lindsay MM, Spence MS, et al
    Percutaneous coronary angioplasty versus coronary artery bypass grafting in the treatment of unprotected left main stenosis: updated 5-year outcomes from the randomised, non-inferiority NOBLE trial.
    Lancet. 2019 Dec 23. pii: S0140-6736(19)32972.
    PubMed     Abstract available


  22. BLAGEV DP, Harris D, Dunn AC, Guidry DW, et al
    Clinical presentation, treatment, and short-term outcomes of lung injury associated with e-cigarettes or vaping: a prospective observational cohort study.
    Lancet. 2019;394:2073-2083.
    PubMed     Abstract available


    November 2019
  23. TOHME-SHAYA F, Pradhan AM
    Innovation in valve repair devices.
    Lancet. 2019;394:1968-1970.
    PubMed    


  24. NICKENIG G, Weber M, Lurz P, von Bardeleben RS, et al
    Transcatheter edge-to-edge repair for reduction of tricuspid regurgitation: 6-month outcomes of the TRILUMINATE single-arm study.
    Lancet. 2019;394:2002-2011.
    PubMed     Abstract available


  25. TCHETCHE D
    Do we need any new TAVR device?
    Lancet. 2019;394:1593-1594.
    PubMed    


    September 2019
  26. LANZ J, Kim WK, Walther T, Burgdorf C, et al
    Safety and efficacy of a self-expanding versus a balloon-expandable bioprosthesis for transcatheter aortic valve replacement in patients with symptomatic severe aortic stenosis: a randomised non-inferiority trial.
    Lancet. 2019 Sep 26. pii: S0140-6736(19)32220.
    PubMed     Abstract available


  27. SUGIMURA K, Sasaki O, Shinoda M, Kawasaki S, et al
    Catamenial pneumothorax: a cause of monthly breathlessness.
    Lancet. 2019;394:952.
    PubMed    


  28. VRANCKX P, Valgimigli M, Eckardt L, Tijssen J, et al
    Edoxaban-based versus vitamin K antagonist-based antithrombotic regimen after successful coronary stenting in patients with atrial fibrillation (ENTRUST-AF PCI): a randomised, open-label, phase 3b trial.
    Lancet. 2019 Sep 2. pii: S0140-6736(19)31872.
    PubMed     Abstract available


    August 2019
  29. THUIJS DJFM, Kappetein AP, Serruys PW, Mohr FW, et al
    Percutaneous coronary intervention versus coronary artery bypass grafting in patients with three-vessel or left main coronary artery disease: 10-year follow-up of the multicentre randomised controlled SYNTAX trial.
    Lancet. 2019 Aug 30. pii: S0140-6736(19)31997.
    PubMed     Abstract available


  30. BHATT DL, Steg PG, Mehta SR, Leiter LA, et al
    Ticagrelor in patients with diabetes and stable coronary artery disease with a history of previous percutaneous coronary intervention (THEMIS-PCI): a phase 3, placebo-controlled, randomised trial.
    Lancet. 2019 Aug 30. pii: S0140-6736(19)31887.
    PubMed     Abstract available


  31. TAGGART DP, Pagano D
    Expansion or contraction of stenting in coronary artery disease?
    Lancet. 2019 Aug 30. pii: S0140-6736(19)32040.
    PubMed    



  32. Perioperative covert stroke in patients undergoing non-cardiac surgery (NeuroVISION): a prospective cohort study.
    Lancet. 2019 Aug 14. pii: S0140-6736(19)31795.
    PubMed     Abstract available


  33. CERDA J
    A biomarker able to predict acute kidney injury before it occurs?
    Lancet. 2019;394:448-450.
    PubMed    


    June 2019
  34. RISSANEN TT, Uskela S, Eranen J, Mantyla P, et al
    Drug-coated balloon for treatment of de-novo coronary artery lesions in patients with high bleeding risk (DEBUT): a single-blind, randomised, non-inferiority trial.
    Lancet. 2019 Jun 13. pii: S0140-6736(19)31126.
    PubMed     Abstract available


  35. SCHUNK SJ, Zarbock A, Meersch M, Kullmar M, et al
    Association between urinary dickkopf-3, acute kidney injury, and subsequent loss of kidney function in patients undergoing cardiac surgery: an observational cohort study.
    Lancet. 2019 Jun 12. pii: S0140-6736(19)30769.
    PubMed     Abstract available


    May 2019
  36. PICCOLO R, Bonaa KH, Efthimiou O, Varenne O, et al
    Drug-eluting or bare-metal stents for percutaneous coronary intervention: a systematic review and individual patient data meta-analysis of randomised clinical trials.
    Lancet. 2019 May 2. pii: S0140-6736(19)30474.
    PubMed     Abstract available


    April 2019
  37. SPAHN DR, Schoenrath F, Spahn GH, Seifert B, et al
    Effect of ultra-short-term treatment of patients with iron deficiency or anaemia undergoing cardiac surgery: a prospective randomised trial.
    Lancet. 2019 Apr 26. pii: S0140-6736(18)32555.
    PubMed     Abstract available


  38. HARE GMT, Mazer CD
    A one-shot solution for improved patient blood management in cardiac surgery?
    Lancet. 2019 Apr 25. pii: S0140-6736(18)32979.
    PubMed    


    February 2019
  39. ZAMAN A, de Winter RJ, Kogame N, Chang CC, et al
    Safety and efficacy of a sirolimus-eluting coronary stent with ultra-thin strut for treatment of atherosclerotic lesions (TALENT): a prospective multicentre randomised controlled trial.
    Lancet. 2019 Feb 28. pii: S0140-6736(18)32467.
    PubMed     Abstract available


    September 2018
  40. LANSKY A, Wijns W, Xu B, Kelbaek H, et al
    Targeted therapy with a localised abluminal groove, low-dose sirolimus-eluting, biodegradable polymer coronary stent (TARGET All Comers): a multicentre, open-label, randomised non-inferiority trial.
    Lancet. 2018 Sep 3. pii: S0140-6736(18)31649.
    PubMed     Abstract available


  41. PILGRIM T, Piccolo R, Heg D, Roffi M, et al
    Ultrathin-strut, biodegradable-polymer, sirolimus-eluting stents versus thin-strut, durable-polymer, everolimus-eluting stents for percutaneous coronary revascularisation: 5-year outcomes of the BIOSCIENCE randomised trial.
    Lancet. 2018;392:737-746.
    PubMed     Abstract available


    August 2018
  42. JEGER RV, Farah A, Ohlow MA, Mangner N, et al
    Drug-coated balloons for small coronary artery disease (BASKET-SMALL 2): an open-label randomised non-inferiority trial.
    Lancet. 2018 Aug 24. pii: S0140-6736(18)31719.
    PubMed     Abstract available


  43. GARBARINO MC, Cani V, Mazzarello P
    A century ago: Carlo Forlanini and the first successful treatment of tuberculosis.
    Lancet. 2018;392:475.
    PubMed    


    July 2018
  44. DOWLING C, Firoozi S, Brecker S
    Percutaneous coronary intervention for stable angina in ORBITA.
    Lancet. 2018;392:28.
    PubMed    


  45. FRANCIS DP, Al-Lamee R
    Percutaneous coronary intervention for stable angina in ORBITA - Authors' reply.
    Lancet. 2018;392:28-30.
    PubMed    


  46. BANNING A, Redwood S
    Percutaneous coronary intervention for stable angina in ORBITA.
    Lancet. 2018;392:28.
    PubMed    


  47. BAUER A, Rizas KD, Massberg S
    Percutaneous coronary intervention for stable angina in ORBITA.
    Lancet. 2018;392:27.
    PubMed    


  48. REED GW, Kapadia SR
    Percutaneous coronary intervention for stable angina in ORBITA.
    Lancet. 2018;392:27-28.
    PubMed    


  49. POCOCK SJ
    Percutaneous coronary intervention for stable angina in ORBITA.
    Lancet. 2018;392:26-27.
    PubMed    


  50. BARAKAT MF, Simitsis P
    Percutaneous coronary intervention for stable angina in ORBITA.
    Lancet. 2018;392:26.
    PubMed    


  51. TU T, Liu Q, Hu X, Zhou S, et al
    Percutaneous coronary intervention for stable angina in ORBITA.
    Lancet. 2018;392:25.
    PubMed    


  52. MUTHALALY RG, Nerlekar N, Brown AJ
    Percutaneous coronary intervention for stable angina in ORBITA.
    Lancet. 2018;392:25-26.
    PubMed    


  53. DEGRELL P, Picard F, Varenne O
    Percutaneous coronary intervention for stable angina in ORBITA.
    Lancet. 2018;392:25.
    PubMed    


    June 2018
  54. WIJEYSUNDERA DN, Pearse RM, Shulman MA, Abbott TEF, et al
    Assessment of functional capacity before major non-cardiac surgery: an international, prospective cohort study.
    Lancet. 2018;391:2631-2640.
    PubMed     Abstract available


  55. DEVEREAUX PJ, Duceppe E, Guyatt G, Tandon V, et al
    Dabigatran in patients with myocardial injury after non-cardiac surgery (MANAGE): an international, randomised, placebo-controlled trial.
    Lancet. 2018;391:2325-2334.
    PubMed     Abstract available


    May 2018
  56. SPADACCIO C, Dalby M, Danton MHD
    Daytime variations in perioperative myocardial injury.
    Lancet. 2018;391:2105-2106.
    PubMed    


  57. LUCCHINETTI E, Zaugg M
    Daytime variations in perioperative myocardial injury.
    Lancet. 2018;391:2104-2105.
    PubMed    


  58. BARTMAN CM, Oyama Y, Eckle T
    Daytime variations in perioperative myocardial injury.
    Lancet. 2018;391:2104.
    PubMed    


  59. JEGER RV, Mobius-Winkler S
    Stents in saphenous vein grafts.
    Lancet. 2018;391:1967-1968.
    PubMed    


    March 2018
  60. HAHN JY, Song YB, Oh JH, Cho DK, et al
    6-month versus 12-month or longer dual antiplatelet therapy after percutaneous coronary intervention in patients with acute coronary syndrome (SMART-DATE): a randomised, open-label, non-inferiority trial.
    Lancet. 2018 Mar 9. pii: S0140-6736(18)30493.
    PubMed     Abstract available


    February 2018
  61. HEAD SJ, Milojevic M, Daemen J, Ahn JM, et al
    Mortality after coronary artery bypass grafting versus percutaneous coronary intervention with stenting for coronary artery disease: a pooled analysis of individual patient data.
    Lancet. 2018 Feb 22. pii: S0140-6736(18)30423.
    PubMed     Abstract available


  62. BHATT DL
    CABG the clear choice for patients with diabetes and multivessel disease.
    Lancet. 2018 Feb 22. pii: S0140-6736(18)30424.
    PubMed    


    January 2018
  63. COLES CE, Haviland JS, Kirby AM, Titley J, et al
    Targeted radiotherapy for early breast cancer - Authors' reply.
    Lancet. 2018;391:27-28.
    PubMed    


  64. BICCARD BM, Madiba TE, Kluyts HL, Munlemvo DM, et al
    Perioperative patient outcomes in the African Surgical Outcomes Study: a 7-day prospective observational cohort study.
    Lancet. 2018 Jan 3. pii: S0140-6736(18)30001.
    PubMed     Abstract available


    December 2017
  65. DE WINTER RJ, Katagiri Y, Asano T, Milewski KP, et al
    A sirolimus-eluting bioabsorbable polymer-coated stent (MiStent) versus an everolimus-eluting durable polymer stent (Xience) after percutaneous coronary intervention (DESSOLVE III): a randomised, single-blind, multicentre, non-inferiority, phase 3 tri
    Lancet. 2017 Dec 1. pii: S0140-6736(17)33103.
    PubMed     Abstract available


    November 2017
  66. AL-LAMEE R, Thompson D, Dehbi HM, Sen S, et al
    Percutaneous coronary intervention in stable angina (ORBITA): a double-blind, randomised controlled trial.
    Lancet. 2017 Nov 1. pii: S0140-6736(17)32714.
    PubMed     Abstract available


    October 2017
  67. MONTAIGNE D, Marechal X, Modine T, Coisne A, et al
    Daytime variation of perioperative myocardial injury in cardiac surgery and its prevention by Rev-Erbalpha antagonism: a single-centre propensity-matched cohort study and a randomised study.
    Lancet. 2017 Oct 26. pii: S0140-6736(17)32132.
    PubMed     Abstract available


    July 2017
  68. WEINTRAUB RG, Semsarian C, Macdonald P
    Dilated cardiomyopathy.
    Lancet. 2017;390:400-414.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Thoracic Surgery is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: